Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis

References

• Mosalpuria K, Bociek RG, Vose JM. Angioimmunoblastic T-cell lymphoma management. Semin Hematol 2014; 51(1):52-8; PMID:24468316; http://dx.doi.org/10.1053/j.seminhematol.2013.11.008
   PubMed Web of Science ®Google Scholar
• Kameoka Y, Takahashi N, Itou S, Kume M, Noji H, Kato Y, Ichikawa Y, Sasaki O, Motegi M, Ishiguro A, et al. Analysis of clinical characteristics and prognostic factors for angioimmunoblastic T-cell lymphoma. Int J Hematol 2015; 101(6):536-42; PMID:25739382; http://dx.doi.org/10.1007/s12185-015-1763-7
   PubMed Web of Science ®Google Scholar
• Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med 1975; 59(6):803-18; PMID:1190254; http://dx.doi.org/10.1016/0002-9343(75)90466-0
   PubMed Web of Science ®Google Scholar
• de Leval L, Gisselbrecht C, Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 2010; 148(5):673-89; PMID:19961485; http://dx.doi.org/10.1111/j.1365-2141.2009.08003.x
   PubMed Web of Science ®Google Scholar
• Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003; 121:681-91
   PubMed Web of Science ®Google Scholar
• Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, Lee NR, Kwak JY, Park BH, Park HS, Chung MJ, et al. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. Am J Surg Pathol 2008; 32:1523-31; PMID:18724249; http://dx.doi.org/10.1097/PAS.0b013e31816b6478
   PubMed Web of Science ®Google Scholar
• Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004; 73:417-35; PMID:15189148; http://dx.doi.org/10.1146/annurev.biochem.73.011303.073651
   PubMed Web of Science ®Google Scholar
• Voelter-Mahlknecht S, Mahlknecht U. Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. Int J Mol Med 2006; 17:59-67; PMID:16328012
   PubMed Web of Science ®Google Scholar
• Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 2005; 6:298-305; PMID:15768047; http://dx.doi.org/10.1038/nrm1616
   PubMed Web of Science ®Google Scholar
• Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001; 107:137-48; PMID:11672522; http://dx.doi.org/10.1016/S0092-8674(01)00524-4
   PubMed Web of Science ®Google Scholar
• Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107:149-59; PMID:11672523; http://dx.doi.org/10.1016/S0092-8674(01)00527-X
   PubMed Web of Science ®Google Scholar
• Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404:1-13; PMID:17447894; http://dx.doi.org/10.1042/BJ20070140
   PubMed Web of Science ®Google Scholar
• Chu F, Chou PM, Zheng X, Mirkin BL, Rebbaa A. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res 2005; 65:10183-7; PMID:16288004; http://dx.doi.org/10.1158/0008-5472.CAN-05-2002
   PubMed Web of Science ®Google Scholar
• Kuzmichev A, Margueron R, Vaquero A, Preissner TS, Scher M, Kirmizis A, Ouyang X, Brockdorff N, Abate-Shen C, Farnham P, et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA 2005; 102:1859-64; PMID:15684044; http://dx.doi.org/10.1073/pnas.0409875102
   PubMed Web of Science ®Google Scholar
• Deng CX. SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 2009; 5:147-52; PMID:19173036
   PubMed Web of Science ®Google Scholar
• Song NY, Surh YJ. Janus-faced role of SIRT1 in tumorigenesis. Ann N Y Acad Sci 2012; 1271:10-19; PMID:23050959; http://dx.doi.org/10.1111/j.1749-6632.2012.06762.x
   PubMed Web of Science ®Google Scholar
• Lim CS. Human SIRT1: a potential biomarker for tumorigenesis? Cell Biol Int 2007; 31:636-7; PMID:17433727; http://dx.doi.org/10.1016/j.cellbi.2006.11.003
   PubMed Web of Science ®Google Scholar
• Dai Y, Faller DV. Transcription Regulation by Class III Histone Deacetylases (HDACs)-Sirtuins. Transl Oncogenomics 2008; 3:53-65; PMID:21566744
   PubMedGoogle Scholar
• Moore RL, Dai Y, Faller DV. Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer. J Endocrinol 2012; 213:37-48; PMID:22159506; http://dx.doi.org/10.1530/JOE-11-0217
   PubMed Web of Science ®Google Scholar
• Nihal M, Ahmad N, Wood GS. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Cell Cycle 2014; 13(4):632-40; PMID:24343700; http://dx.doi.org/10.4161/cc.27523
   PubMed Web of Science ®Google Scholar
• Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303:2011-5; PMID:14976264; http://dx.doi.org/10.1126/science.1094637
   PubMed Web of Science ®Google Scholar
• Frazzi R, Valli R, Tamagnini I, Casali B, Latruffe N, Merli F. Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation. Int J Cancer 2013; 132(5):1013-21; PMID:22833338; http://dx.doi.org/10.1002/ijc.27748
   PubMed Web of Science ®Google Scholar
• Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005; 123:437-48; PMID:16269335; http://dx.doi.org/10.1016/j.cell.2005.08.011
   PubMed Web of Science ®Google Scholar
• Zschoernig B, Mahlknecht U. SIRTUIN 1: Regulating the regulator. Biochem Biophys Res Commun 2008; 376:251-5; PMID:18774777; http://dx.doi.org/10.1016/j.bbrc.2008.08.137
   PubMed Web of Science ®Google Scholar
• Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner A, Loerch P, et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 2008; 135:907-18; PMID:19041753; http://dx.doi.org/10.1016/j.cell.2008.10.025
   PubMed Web of Science ®Google Scholar
• Kozako T, Aikawa A, Shoji T, Fujimoto T, Yoshimitsu M, Shirasawa S, Tanaka H, Honda S, Shimeno H, Arima N, et al. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells. Int J Cancer 2012; 131(9):2044-55; PMID:22322739; http://dx.doi.org/10.1002/ijc.27481
   PubMed Web of Science ®Google Scholar